Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is Double-Blind, Placebo-Controlled Multicentre Clinical Phase III Study conducted in 10 medical facilities. The objective of the study is to evaluate efficacy and safety of the drug Drug RADAMIN®VIRO, Lyophilisate for Preparation of Solution for Intramuscular and Subcutaneous Administration for COVID-19 Postexposure Prophylaxis
Epistemonikos ID: 34ca07efbf93439143fbef31f4fd66eec157acac
First added on: Feb 11, 2023